OPT ASX Chart
Snapshot
Opthea Limited (OPT) develops and commercialize therapies primarily for eye disease. Opthea's lead asset, sozinibercept (OPT-302), is a soluble form of vascular endothelial growth factor receptor-3 âVEGFR-3" in clinical development as a novel therapy for wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Wet AMD and DME are leading causes of blindness in the elderly and diabetic populations respectively and are increasing in prevalence worldwide.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +160.99% |
vs ASX 200 (1yr) | +170.52% |
Announcements
Corporate Overview
Corporate Details
Head Office | South Yarra VIC 3141 |
Website | www.opthea.com |
Registry | Computershare |
Auditor | Deloitte Touche Tohmatsu |
Date Listed | 18 Apr 1991 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
Former Company Names
- Circadian Technologies Limited (CIR), 11/12/2015
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
OPT directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of OPT directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Bank of New York Mellon Corporation | 02/08/2024 | 92,356,273 | 7.50 |
Regal Funds Management Pty Ltd | 02/08/2024 | 381,556,238 | 30.99 |
Vanguard Group | 30/09/2024 | 62,130,152 | 5.05 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
30-09-24 | Vanguard Group | 62,130,152 | -- | 5.05 |
17-07-24 | Regal Funds Management Pty Limited | 91,822,635 | 26.81 | 35.22 |
21-06-24 | The Bank of New York Mellon Corporation | 2,788,360 | 14.93 | 8.84 |
21-06-24 | Regal Funds Management Pty Limited | 160,746,139 | 19.89 | 26.81 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
17-07-24 | The Bank of New York Mellon Corporation | 4,079,192 | 8.84 | 7.50 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.35 | 28 June |
2023 | $0.55 | 30 June |
2022 | $1.10 | 30 June |
2021 | $1.34 | 30 June |
2020 | $2.36 | 30 June |
2019 | $0.67 | 28 June |
2018 | $0.525 | 29 June |
2017 | $0.75 | 30 June |
2016 | $0.495 | 30 June |
2015 | $0.185 | 30 June |
2014 | $0.19 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.